Julie McHugh

CIK: 0001487179

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (33.3%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

IRWD

IRONWOOD PHARMACEUTICALS INC

Director

LNTH

Lantheus Holdings, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

IRWD
IRONWOOD PHARMACEUTICALS INC
Jun 16, 2026
Award(A)
Direct
63.5K shares-
IRWD
IRONWOOD PHARMACEUTICALS INC
Jun 16, 2026
Sale(S)
Direct
21.6K shares at avg. $3.73$80K
LNTH
Lantheus Holdings, Inc.
May 14, 2026
Award(A)
Direct
4.1K shares-
IRWD
IRONWOOD PHARMACEUTICALS INC
Jun 10, 2025
Award(A)
Direct
45K shares-
LNTH
Lantheus Holdings, Inc.
Jun 9, 2025
Sale(S)
Direct
5.2K shares at avg. $81.62$424K
LNTH
Lantheus Holdings, Inc.
May 14, 2025
Award(A)
Direct
2.5K shares-

		Type	Shares	Price		Ownership
Jun 16, 2026	IRWD IRONWOOD PHARMACEUTICALS INC	Award(A)	63,481	-	$0	Direct
Jun 16, 2026	IRWD IRONWOOD PHARMACEUTICALS INC	Sale(S)	21,571	$3.73	$80,460	Direct
May 14, 2026	LNTH Lantheus Holdings, Inc.	Award(A)	4,137	-	$0	Direct
Jun 10, 2025	IRWD IRONWOOD PHARMACEUTICALS INC	Award(A)	45,000	-	-	Direct
Jun 9, 2025	LNTH Lantheus Holdings, Inc.	Sale(S)	5,192	$81.62	$423,771	Direct
May 14, 2025	LNTH Lantheus Holdings, Inc.	Award(A)	2,537	-	-	Direct

1-6 of 6 transactions

About McHugh Julie

McHugh Julie (SEC CIK 0001487179) files insider reports with the SEC as Director of IRONWOOD PHARMACEUTICALS INC (IRWD) and Director of Lantheus Holdings, Inc. (LNTH).

Signal8 holds 5 ownership filings by McHugh Julie, all Form 4s, filed between May 16, 2025 and Jun 17, 2026. Those filings report 6 transactions, from May 14, 2025 to Jun 16, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on McHugh Julie's filings is in BOSTON, MA.

Recent filings by McHugh Julie

Jun 16, 2026: Grant or award of IRWD shares (Form 4, code A).
Jun 16, 2026: Open-market sale of IRWD shares (Form 4, code S).
May 14, 2026: Grant or award of LNTH shares (Form 4, code A).
Jun 10, 2025: Grant or award of IRWD shares (Form 4, code A).
Jun 9, 2025: Open-market sale of LNTH shares (Form 4, code S).

Other insiders filing for IRONWOOD PHARMACEUTICALS INC (IRWD)

DENNER ALEXANDER J, Director
Silber Jeffrey, SVP, CMO, Head-Res&Drug
Silver Ronald, PFO & PAO
Shepard Jay, Director
Kessler Marla L, Director
Currie Mark G, Director

How to read Form 4 transaction codes